2022
DOI: 10.26434/chemrxiv-2022-xk9wv
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

‘Omic-scale quantitative HILIC-MS/MS approach for circulatory lipid phenotyping in clinical research

Abstract: Lipid analysis at the molecular species level represents a valuable opportunity for clinical applications due to the essential roles that lipids play in metabolic health. However, a comprehensive and high-throughput lipid profiling remains challenging given the lipid structural complexity and exceptional diversity. Herein, we present an ‘omic-scale targeted LC-MS/MS approach for the straightforward and high-throughput quantification of a broad panel of complex lipid species across 21 lipid (sub)classes. The wo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 70 publications
(126 reference statements)
0
2
0
Order By: Relevance
“…To quantify an extensive panel of circulating sphingolipids (n=61), a high-coverage method using reversed-phase liquid chromatography coupled to tandem mass spectrometry (RPLC-MS/MS) will be applied, as previously described. 7…”
Section: Sphingolipidomicsmentioning
confidence: 99%
See 1 more Smart Citation
“…To quantify an extensive panel of circulating sphingolipids (n=61), a high-coverage method using reversed-phase liquid chromatography coupled to tandem mass spectrometry (RPLC-MS/MS) will be applied, as previously described. 7…”
Section: Sphingolipidomicsmentioning
confidence: 99%
“…4 However, technological advances in mass spectrometry now allow to quantify less abundant circulating lipids such as sphingolipids. [5][6][7] Sphingolipids constitute a family of important bioactive lipids, which modulate numerous biological processes and are involved in the pathogenesis of coronary artery disease, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease. [8][9][10] This suggests that comprehensive sphingolipid panels should be considered surrogates of cardiometabolic health.…”
Section: Introductionmentioning
confidence: 99%